The NSCLC market is experiencing significant growth driven by increasing incidence rates and breakthroughs in precision medicine. Leading companies including Merck (Keytruda), Roche (Tecentriq), and AstraZeneca (Tagrisso) are pioneering innovative immuno-oncology agents and targeted therapies that are transforming treatment paradigms and improving survival outcomes for patients worldwide. Download Market Analysis: https://www.delveinsight.com/infographics/non-small-cell-lung-cancer-market?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr